A detailed history of Encompass More Asset Management transactions in Novo Nordisk A S stock. As of the latest transaction made, Encompass More Asset Management holds 2,269 shares of NVO stock, worth $198,877. This represents 0.1% of its overall portfolio holdings.

Number of Shares
2,269
Previous 1,984 14.36%
Holding current value
$198,877
Previous $283 Million 4.6%
% of portfolio
0.1%
Previous 0.2%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$119.07 - $145.42 $33,934 - $41,444
285 Added 14.36%
2,269 $270 Million
Q2 2024

Jul 26, 2024

BUY
$122.71 - $146.91 $5,767 - $6,904
47 Added 2.43%
1,984 $283 Million
Q1 2024

May 10, 2024

SELL
$102.11 - $135.92 $22,055 - $29,358
-216 Reduced 10.03%
1,937 $249 Million
Q4 2023

Feb 15, 2024

BUY
$87.78 - $105.45 $188,990 - $227,033
2,153 New
2,153 $223 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $198B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Encompass More Asset Management Portfolio

Follow Encompass More Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Encompass More Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Encompass More Asset Management with notifications on news.